Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Dec;26(12):7091-7092.
doi: 10.1038/s41380-021-01221-y. Epub 2021 Jul 19.

Can antidepressants unlock prescription of rimonabant in the fight against COVID-19?

Juliette Salles  1   2 , Fabienne Briand-Mésange  1 , Stéphanie Trudel  1   3 , Jérôme Ausseil  1   3 , Jean-Pierre Salles  1   4 , Hugues Chap  5
Affiliations
Comment

Can antidepressants unlock prescription of rimonabant in the fight against COVID-19?

Juliette Salles et al. Mol Psychiatry. 2021 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Comment in

Comment on

References

    1. Hoertel N, Sánchez-Rico M, Vernet R, Beeker N, Jannot AS, Neuraz A, et al. Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study. Mol Psychiatry. 2021. 10.1038/s41380-021-01021-4. - PubMed
    1. Lenze EJ, Mattar C, Zorumski CF, Stevens A, Schweiger J, Nicol GE, et al. Fluvoxamine vs placebo and clinical deterioration in outpatients with symptomatic COVID-19: a randomized clinical trial. JAMA. 2020;324:2292–2300. doi: 10.1001/jama.2020.22760. - DOI - PMC - PubMed
    1. Briand-Mésange F, Trudel S, Salles J, Ausseil J, Salles JP, Chap H. Possible role of adipose tissue and the endocannabinoid system in coronavirus disease 2019 pathogenesis: can rimonabant return? Obesity. 2020;28:1580–1. doi: 10.1002/oby.22916. - DOI - PMC - PubMed
    1. Cinar R, Iyer MR, Kunos G. Dual inhibition of CB1 receptors and iNOS, as a potential novel approach to the pharmacological management of acute and long COVID-19. Br J Pharmacol. 2021. 10.1111/bph.15461. - PMC - PubMed
    1. Carpinteiro A, Edwards MJ, Hoffmann M, Kochs G, Gripp B, Weigang S, et al. Pharmacological inhibition of acid sphingomyelinase prevents uptake of SARS-CoV-2 by epithelial cells. Cell Rep Med. 2020;1:100142. doi: 10.1016/j.xcrm.2020.100142. - DOI - PMC - PubMed